The Weekly Litigation News Digest is now live. Subscribe now

Intranasal Pharmaceutical Dosage Forms Comprising Naloxone - EP2706982

The patent EP2706982 was granted to Euro Celtique on Mar 10, 2021. The application was originally filed on May 11, 2012 under application number EP12721507A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2706982

EURO CELTIQUE
Application Number
EP12721507A
Filing Date
May 11, 2012
Status
Patent Maintained As Amended
Feb 5, 2021
Publication Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREOct 1, 2018BOOTHWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN1575795
INTERNATIONAL-SEARCH-REPORTWO0062757
INTERNATIONAL-SEARCH-REPORTWO8203768
OPPOSITIONCN1575795
OPPOSITIONWO0062757
OPPOSITIONWO8203768
OTHERCN1575795
OTHERUS2006009447
OTHERWO0062757
OTHERWO8203768

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents